Advertisement

Topics

Arrowhead Pharmaceuticals nets $56.7mm in FOPO

14:40 EST 25 Jan 2018 | Elsevier Business Intelligence

Arrowhead Pharmaceuticals Inc. (gene silencing) netted $56.7mm in a follow-on public offering of 11.5 common shares (includin...

Original Article: Arrowhead Pharmaceuticals nets $56.7mm in FOPO

NEXT ARTICLE

More From BioPortfolio on "Arrowhead Pharmaceuticals nets $56.7mm in FOPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...